| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.0009 |